{
    "organizations": [],
    "uuid": "6c52faa4f9dac28c3f54cad9bd01cc61179799af",
    "author": "",
    "url": "https://www.reuters.com/article/brief-argos-therapeutics-reports-q4-loss/brief-argos-therapeutics-reports-q4-loss-per-share-0-38-idUSASC09UGF",
    "ord_in_thread": 0,
    "title": "BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2, 2018 / 12:34 PM / in 8 minutes BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38 Reuters Staff \nApril 2 (Reuters) - Argos Therapeutics Inc: \n* ARGOS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS * QTRLY LOSS PER SHARE $0.38 \n* AS OF DECEMBER 31, 2017, CASH AND CASH EQUIVALENTS TOTALED $15.2 MILLION \n* EXPECTS CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS THROUGH END OF 2018  ",
    "published": "2018-04-02T15:33:00.000+03:00",
    "crawled": "2018-04-02T15:49:23.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "therapeutic",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "april",
        "reuters",
        "argo",
        "therapeutic",
        "inc",
        "argo",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "operational",
        "highlight",
        "qtrly",
        "loss",
        "per",
        "share",
        "december",
        "cash",
        "cash",
        "equivalent",
        "totaled",
        "million",
        "expects",
        "current",
        "cash",
        "cash",
        "equivalent",
        "sufficient",
        "fund",
        "operation",
        "end"
    ]
}